International Journal of Immunotherapy and Cancer Research is a multi-disciplinary peer-reviewed, open access journal. Journal brings together all the varied aspects of research that will ultimately lead to the prevention of cancer. With the goal of advancing technology and improving health care by bringing researchers and practitioners together from academia and industryRead more
CHA University, Republic of KoreaEmail: email@example.com
Research Interest: Molecular carcinogenesis of schistosome associated squamous cell carcinoma of the bladder with mouse experiments as models of carcinogenesis; Effects of schistosoma-derived estrogenic molecules on cell lines and the accumulation and biodistribution of these molecules in animal models, and their possible carcinogenic effect; Schistosomiasis associated catechol-estrogens.
Research Interest: RNA interefence, Immunotherapy and Immunodiagnostics
Research Interest: Lab Medicine, Clinical Chemistry, Endocrinology and Immunology.
Research Interest: Leukemia and lymphoma – clinical aspects, Adjuvant treatments in malignant hemopathies (e.g. resveratrol, statins), Connections between malignant hemopathies and dyslipidemia or metabolic syndrome, Thrombin generation in malignant hemopathies
Research Interest: Malignant transformation, including DNA Repair mechanisms, roles of Cytoskeleton in signal transduction, Developmental processes
Research Interest: Biophysics; Development of animal models for human diseases (cancer, cardiac ischemia); Nuclear Oncology (from molecular biology to molecular imaging); Photodynamic therapy in models in vitro and in vivo; Radiopharmacy.
Research Interest: Head and neck oncology, molecular as well as clinically molecular rhinology
Research Interest: Cancer Genetics, Apoptosis, Oncogenes, Tumor
Suppressor Genes, Mechanisms of Anti-Cancer Drug Resistance.
1. Development of mouse models for understanding and treating cancer
2. Understanding of therapies that target immune checkpoints.
3. Tumor Biomarkers: MicroRNA signature predictive of prostate cancer recurrence and metastasis
4. Clinical Genomics: Application of genomics data in a clinical setting
Research Interest: Research areas of human physiology and pathophysiology. His research focuses on the clinical evaluation of new biomarkers and molecular mediators in several pathophysiological disease states, such as diabetes, atherosclerosis and cancer. His research interest also includes the development of quantitative structure-activity relationships (QSARs) and quantitative structure-property relationships (QSPRs) in the area of toxicology and pharmacology. Furthermore, his research interest lies in the assessment of physicochemical properties, such as lipophilicity, solubility and ionization of drugs, natural bioactive compounds and toxic chemicals in relation with their potential biological activity and toxicity endpoints, as well as their Absorption/Distribution/Metabolism/Excretion (ADME) parameters and their pharmacokinetic and toxicokinetic profiles
Research Interest: Tumours Role of transcription factors for angiogenesis, tumour invasion and metastasis Interaction of tumour cells and cells of the tumour stroma Translational research Molecular targeting therapy Biochemical, immunological and pharmacological assays for characterization of the efficacy of different therapeutic agents Tumour immunology Immune evasion mechanism of tumour cells.
Research Interest: Immunology and Virology
Research Interest: Development of new DNA vaccines and adjuvants for anticancer therapy and/or prevention, intended for clinical application. Preclinical protocols of genetic immunization against tumor-associated antigens Combined therapeutic protocols (vaccination+immunotherapy+chemotherapy) in preclinical research.
Research Interest: Oncology, urologic oncology, targeted therapy,
cancer genomics and prostate cancer.
Research Interest: Molecular mechanisms and signaling pathways underlying cancer progressi on, metastasis and chem resistance
Published On: August 22, 2017 | Pages: 034 - 040View Article DOI: 10.17352/2455-8591.000017
Published On: May 20, 2017 | Pages: 032 - 033View Article DOI: 10.17352/2455-8591.000016
Published On: April 17, 2017 | Pages: 019 - 031View Article DOI: 10.17352/2455-8591.000015
Published On: March 31, 2017 | Pages: 015 - 018View Article DOI: 10.17352/2455-8591.000014
Published On: February 03, 2017 | Pages: 012 - 014View Article DOI: 10.17352/2455-8591.000013
Published On: February 01, 2017 | Pages: 007 - 011View Article DOI: 10.17352/2455-8591.000012
Published On: February 01, 2017 | Pages: 001 - 006View Article DOI: 10.17352/2455-8591.000011
Published On: December 31, 2016 | Pages: 014 - 016View Article DOI: 10.17352/2455-8591.000010
Published On: October 06, 2016 | Pages: 011 - 013View Article DOI: 10.17352/2455-8591.000009
Published On: June 17, 2016 | Pages: 003 - 010View Article DOI: 10.17352/2455-8591.000008